TRIBUNE-REVIEW — When drug ma...
As the battle against HIV continues, Pitt Men’s Study volunteer joins coronavirus vaccine study
TRIBUNE-REVIEW — When drug makers solicited volunteers to test a coronavirus vaccine, Marc Wagner jumped. It was a matter of giving back. Wagner felt compelled to do his part for science. But just as important, it was an opportunity for him to honor the herculean efforts of scientists and others he... (11/30/2020)
PHILADELPHIA INQUIRER — Monoc...
Monoclonal antibody drugs raise hopes for keeping high-risk COVID-19 patients out of the hospital. But it’s complicated.
PHILADELPHIA INQUIRER — Monoclonal antibodies are not magic bullets. They must be given intravenously in a hospital or infusion center where COVID-19 poses a particular danger to immune-compromised chemotherapy patients. HPM's Walid Gellad summarizes “We don’t want people running to the emergency r... (11/25/2020)
TRIBUNE-REVIEW — IDM's Amy ...
Why a vaccine won’t end the covid pandemic
TRIBUNE-REVIEW — IDM's Amy Hartman said the early results from vaccine trials have her feeling more optimistic than she’s been throughout the pandemic. But, she cautioned, “it’s important to keep in mind that vaccines aren’t necessarily a finite ‘solution’ but they are an important step toward ... (11/25/2020)
THE PHILLY VOICE — Wendy King...
Pitt Scientists Demonstrate Positive Effects of Physical Activity in Patients and Identify Predictors of Satisfaction after Bariatric Surgery
THE PHILLY VOICE — Wendy King, associate professor of epidemiology, found that higher physical activity levels after bariatric surgery lessen depressive symptoms and improve mental and physical quality of life, irrespective of weight loss. Gretchen White's study identified patient characteristics, ... (11/24/2020)
MILWAUKEE JOURNAL SENTINEL - ...
Emergency use of COVID-19 vaccines likely in weeks, though U.S. still headed for a harsh winter
MILWAUKEE JOURNAL SENTINEL - "Vaccination of select high-risk individuals may start by the end of the year, but most likely the majority of vaccines will be released during the first quarter of 2021," said IDM's Amy Hartman. Vaccine makers still need to gather results from larger groups of recipien... (11/24/2020)